Roger Jeffs

Insider Reports History

Entity
Individual
Signature
/s/ Nick Pizzie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roger Jeffs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Liquidia Corp Chief Executive Officer, Director Common Stock 1.54M $18.2M $11.78 Jan 11, 2025 Indirect
Liquidia Corp Chief Executive Officer, Director Common Stock 1.02M $12M $11.78 Jan 14, 2025 Direct
Axsome Therapeutics, Inc. Director Common Stock 121K $8.65M $71.61 Mar 15, 2024 Direct
Axsome Therapeutics, Inc. Director Common Stock 46.9K $3.36M $71.61 Mar 14, 2024 GRAT
Liquidia Corp Chief Executive Officer, Director Performance Stock Units 229K $2.7M $11.78 Jan 11, 2025 Direct
Axsome Therapeutics, Inc. Director Stock Option (Right to Buy) 1.41K $4.93K $3.50 Feb 21, 2025 Direct
ALBIREO PHARMA, INC. Director Stock Option (right to buy) 8K Jun 24, 2021 Direct

Insider Reports Filed by Roger Jeffs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AXSM Axsome Therapeutics, Inc. Feb 21, 2025 1 $0 4 Feb 25, 2025 Director
LQDA Liquidia Corp Jan 11, 2025 3 -$263K 4 Jan 14, 2025 Chief Executive Officer, Director
LQDA Liquidia Corp Oct 14, 2024 1 -$89.5K 4 Oct 15, 2024 Chief Executive Officer, Director
LQDA Liquidia Corp Jul 12, 2024 1 -$101K 4 Jul 15, 2024 Chief Executive Officer, Director
AXSM Axsome Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
LQDA Liquidia Corp Apr 12, 2024 1 -$122K 4 Apr 16, 2024 Chief Executive Officer, Director
LQDA Liquidia Corp Mar 18, 2024 1 -$452K 4 Mar 19, 2024 Chief Executive Officer, Director
AXSM Axsome Therapeutics, Inc. Mar 14, 2024 9 -$1.47M 4 Mar 15, 2024 Director
AXSM Axsome Therapeutics, Inc. Feb 27, 2024 1 $0 4 Feb 29, 2024 Director
LQDA Liquidia Corp Jan 11, 2024 2 $0 4 Jan 16, 2024 Chief Executive Officer, Director
LQDA Liquidia Corp Dec 14, 2023 1 $1M 4 Dec 18, 2023 Chief Executive Officer, Director
AXSM Axsome Therapeutics, Inc. Jun 2, 2023 1 $0 4 Jun 6, 2023 Director
AXSM Axsome Therapeutics, Inc. Mar 2, 2023 1 $0 4 Mar 6, 2023 Director
LQDA Liquidia Corp Jan 11, 2023 2 $0 4 Jan 13, 2023 Chief Executive Officer, Director
LQDA Liquidia Corp Jan 3, 2023 2 $0 4 Jan 5, 2023 Chief Executive Officer, Director
LQDA Liquidia Corp Sep 6, 2022 1 $244K 4 Sep 7, 2022 Chief Executive Officer, Director
LQDA Liquidia Corp Aug 31, 2022 1 $4.87K 4/A Apr 10, 2023 Chief Executive Officer, Director
LQDA Liquidia Corp Jun 17, 2022 1 $0 4 Jun 22, 2022 Chief Executive Officer, Director
AXSM Axsome Therapeutics, Inc. Jun 3, 2022 1 $0 4 Jun 7, 2022 Director
LQDA Liquidia Corp May 24, 2022 1 $98.8K 4 May 25, 2022 Chief Executive Officer, Director
LQDA Liquidia Corp Apr 3, 2022 2 $0 4 Oct 4, 2022 Chief Executive Officer, Director
LQDA Liquidia Corp Mar 31, 2022 1 $0 4 Apr 20, 2022 Chief Executive Officer, Director
AXSM Axsome Therapeutics, Inc. Mar 4, 2022 1 $0 4 Mar 8, 2022 Director
LQDA Liquidia Corp Jan 3, 2022 2 $0 4 Jan 4, 2022 Chief Executive Officer, Director
AXSM Axsome Therapeutics, Inc. Nov 19, 2021 1 $147K 4 Nov 23, 2021 Director
LQDA Liquidia Corp Aug 20, 2021 1 $0 4 Sep 1, 2021 Director
ALBO ALBIREO PHARMA, INC. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director
AXSM Axsome Therapeutics, Inc. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director